Irena Royzman
March 24, 2023 | National Law Journal
Why the Supreme Court Should Reject Attempts to Monopolize a Therapeutic TargetPatents that lay claim to all antibody therapeutics for a biological target stifle medical innovation and hurt patients.
By Irena Royzman
5 minute read
April 25, 2016 | Corporate Counsel
Breakthrough Technology Is Caught in Epic Patent BattleA new gene-editing technique called CRISPR has taken biology by storm. But CRISPR is now embroiled in a massive patent fight between the research institutions laying claim to the technology.
By Irena Royzman and Benjamin H. Weissman
16 minute read
June 12, 2015 | Corporate Counsel
IPR Puts Biotech in the CrosshairsA forum to invalidate patents is now being used on biotech firms.
By Irena Royzman and Zhiqiang Liu
7 minute read
June 11, 2015 | Corporate Counsel
IPR Puts Biotech in the CrosshairsA forum to invalidate patents is now being used on biotech firms.
By Irena Royzman and Zhiqiang Liu
7 minute read
Trending Stories
- 1Commission Confirms Three of Newsom's Appellate Court Picks
- 2Judge Grants Special Counsel's Motion, Dismisses Criminal Case Against Trump Without Prejudice
- 3GEICO, Travelers to Pay NY $11.3M for Cybersecurity Breaches
- 4'Professional Misconduct': Maryland Supreme Court Disbars 86-Year-Old Attorney
- 5Capital Markets Partners Expect IPO Resurgence During Trump Administration
More from ALM
- Legal Speak at General Counsel Conference East 2024: Match Group's Katie Dugan & Herrick's Carol Goodman 1 minute read
- Legal Speak at General Counsel Conference East 2024: Eric Wall, Executive VP, Syllo 1 minute read
- Legal Speak at General Counsel Conference East 2024: Virginia Griffith, Director of Business Development at OutsideGC 1 minute read